Ignite Creation Date:
2024-05-06 @ 2:12 PM
Last Modification Date:
2024-10-26 @ 1:27 PM
Study NCT ID:
NCT04248569
Status:
RECRUITING
Last Update Posted:
2024-06-07
First Post:
2020-01-28
Brief Title:
DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Fibrolamellar Hepatocellular Carcinoma
Sponsor:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-04-20
Start Date Type:
ACTUAL
Primary Completion Date:
2027-03-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-03-01
Completion Date Type:
ESTIMATED
First Submit Date:
2020-01-28
First Submit QC Date:
January 28 2020
Study First Post Date:
2020-01-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-06-05
Last Update Post Date:
2024-06-07
Last Update Post Date Type:
ACTUAL